INNOVENT BIO 01801
91.9500.16%( -0.150 )
Oct 13 · End-of-day data, not live · Hong Kong Stock Exchange
INNOVENT BIO (01801) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| De-Chao Michael YuExecutive Director | 7.49% | 130.21M | |
| Fullerton Management Pte Ltd | 6.77% | 75.71M | |
| Eight Roads Investments | 5.20% | 60.04M | |
| JPMorgan Chase & Co. | 5.06% | 88.35M | |
| BlackRock, Inc. | 5.01% | 87.52M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
| Shareholder | Price | Type | Stake | ||||
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 452.60K | -- | Shares lent | 87.52M | 5.01% | ||
| BlackRock, Inc. | 125.74K | -- | Lent shares recalled | 89.27M | 5.12% | ||
| BlackRock, Inc. | 1.01M | -- | Lent shares recalled | 89.59M | 5.13% | ||
| BlackRock, Inc. | 594.00K | -- | Shares lent | 89.22M | 5.11% | ||
| Temasek Holdings (Private) Limited | 665.50K | 103.34 | Ceased to be notifiable | 86.74M | 4.97% | ||
| BlackRock, Inc. | 524.52K | -- | Lent shares recalled | 87.77M | 5.03% | ||
| JPMorgan Chase & Co. | 2.36M | 102.24 | Bought | 88.35M | 5.06% | ||
| BlackRock, Inc. | 243.22K | -- | Shares lent | 87.67M | 5.03% | ||
| BlackRock, Inc. | 159.00K | -- | Shares lent | 87.62M | 5.03% | ||
| BlackRock, Inc. | 522.29K | -- | Lent shares recalled | 87.54M | 5.02% | ||
| BlackRock, Inc. | 136.54K | -- | Lent shares recalled | 87.32M | 5.01% | ||
| BlackRock, Inc. | 139.50K | 95.38 | Bought | 87.32M | 5.01% | ||
| BlackRock, Inc. | 240.35K | -- | Security interest released | 87.11M | 4.99% | ||
| BlackRock, Inc. | 235.00K | -- | Shares lent | 87.27M | 5.00% | ||
| BlackRock, Inc. | 240.36K | -- | Security interest acquired | 87.27M | 5.00% | ||
| BlackRock, Inc. | 3.54M | -- | Security interest released | 87.05M | 4.99% | ||
| JPMorgan Chase & Co. | 904.40K | 90.68 | Ceased to be notifiable | 86.36M | 4.95% | ||
| JPMorgan Chase & Co. | 483.79K | 86.57 | Other event | 87.26M | 5.01% | ||
| BlackRock, Inc. | 107.00K | -- | Shares lent | 87.16M | 5.01% | ||
| JPMorgan Chase & Co. | 2.19M | 88.18 | Ceased to be notifiable | 85.92M | 4.93% | ||
| Temasek Holdings (Private) Limited | 2.12M | -- | Derivatives acquired | 87.55M | 5.03% | ||
| BlackRock, Inc. | 170.00K | -- | Shares lent | 89.36M | 5.13% | ||
| BlackRock, Inc. | 439.00K | -- | Shares lent | 90.21M | 5.18% | ||
| JPMorgan Chase & Co. | 1.07M | 75.40 | Bought | 87.20M | 5.01% | ||
| JPMorgan Chase & Co. | 393.45K | 73.06 | Ceased to be notifiable | 86.67M | 4.98% | ||
| JPMorgan Chase & Co. | 724.87K | 73.42 | Security interest acquired | 87.06M | 5.00% |
This page shows the major shareholders of INNOVENT BIO (01801) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
